BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

967 related articles for article (PubMed ID: 37164640)

  • 1. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years.
    Maccarrone M; Di Marzo V; Gertsch J; Grether U; Howlett AC; Hua T; Makriyannis A; Piomelli D; Ueda N; van der Stelt M
    Pharmacol Rev; 2023 Sep; 75(5):885-958. PubMed ID: 37164640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis as a Source of Approved Drugs: A New Look at an Old Problem.
    Gabarin A; Yarmolinsky L; Budovsky A; Khalfin B; Ben-Shabat S
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of cannabinoid receptors in cancer.
    Pennant NM; Hinton CV
    WIREs Mech Dis; 2023; 15(4):e1602. PubMed ID: 36750231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.
    Aly E; Masocha W
    IBRO Neurosci Rep; 2021 Jun; 10():109-118. PubMed ID: 34179865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond THC and Endocannabinoids.
    Pacher P; Kogan NM; Mechoulam R
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():637-659. PubMed ID: 31580774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis y los sistemas exocannabinoide y endocannabinoide. Su uso y controversias.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):508-512. PubMed ID: 31695229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytocannabinoid Pharmacology: Medicinal Properties of
    Sampson PB
    J Nat Prod; 2021 Jan; 84(1):142-160. PubMed ID: 33356248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally Occurring Cannabinoids and their Role in Modulation of Cardiovascular Health.
    Karimian Azari E; Kerrigan A; O'Connor A
    J Diet Suppl; 2020; 17(5):625-650. PubMed ID: 32677481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unveiling the angiogenic effects of cannabinoids: Enhancers or inhibitors?
    Maia J; Fonseca BM; Teixeira N; Correia-da-Silva G
    Biochem Pharmacol; 2023 Sep; 215():115686. PubMed ID: 37463627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases.
    Lowe H; Toyang N; Steele B; Bryant J; Ngwa W
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids and the expanded endocannabinoid system in neurological disorders.
    Cristino L; Bisogno T; Di Marzo V
    Nat Rev Neurol; 2020 Jan; 16(1):9-29. PubMed ID: 31831863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Potential for Cannabinoids in Sports Medicine: Current Literature Review.
    Naik H; Trojian TH
    Curr Sports Med Rep; 2021 Jul; 20(7):345-350. PubMed ID: 34234089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use.
    Blebea NM; Pricopie AI; Vlad RA; Hancu G
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment.
    Asth L; Iglesias LP; De Oliveira AC; Moraes MFD; Moreira FA
    Epilepsy Behav; 2021 Aug; 121(Pt B):106832. PubMed ID: 31839498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endocannabinoid system.
    Kilaru A; Chapman KD
    Essays Biochem; 2020 Sep; 64(3):485-499. PubMed ID: 32648908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Pharmacology of Phytocannabinoids.
    Turner SE; Williams CM; Iversen L; Whalley BJ
    Prog Chem Org Nat Prod; 2017; 103():61-101. PubMed ID: 28120231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.